Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Sep 26, 2026, 7:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–15 of 15 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Intervention: Transurethral Resection of Prostate (TURP) Clear all

Conditions: Urinary Incontinence, Stress
Interventions: The AMS Male Transobturator Sling System, AdVance Male Sling; Device
Lead sponsor: American Medical Systems; Industry
Eligibility: 40 Years and older · Male only
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 10
States / cities: Los Angeles, California • Denver, Colorado • Ann Arbor, Michigan + 7 more

Conditions: Prostate Cancer
Interventions: Not listed
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older · Male only
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2017
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Transurethral Resection of the Prostate
Interventions: Not listed
Lead sponsor: Benaroya Research Institute; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Benign Prostatic Hyperplasia
Interventions: GreenLight HPS; Device
Lead sponsor: American Medical Systems; Industry
Eligibility: 45 Years and older · Male only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 9
States / cities: Los Angeles, California • Middlebury, Connecticut • Roswell, Georgia + 6 more

Conditions: Benign Prostatic Hyperplasia
Interventions: Embosphere Microspheres, TURP; Device · Procedure
Lead sponsor: Merit Medical Systems, Inc.; Industry
Eligibility: 50 Years to 79 Years · Male only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 10
States / cities: Long Beach, California • Los Angeles, California • Stanford, California + 6 more

Conditions: Pain, BPH With Urinary Obstruction, BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms
Interventions: Ibuprofen 600 mg, Education; Drug · Behavioral
Lead sponsor: Benaroya Research Institute; Other
Eligibility: 18 Years and older · Male only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Benign Prostatic Hypertrophy (BPH), Lower Urinary Track Symptoms
Interventions: Survey using a questionnaire.; Other
Lead sponsor: Benaroya Research Institute; Other
Eligibility: 18 Years and older · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Benign Prostatic Hyperplasia (BPH)
Interventions: Aquablation; Device
Lead sponsor: PROCEPT BioRobotics; Industry
Eligibility: 45 Years to 80 Years · Male only
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 13
States / cities: Phoenix, Arizona • Long Beach, California • Los Angeles, California + 10 more

Conditions: Benign Prostatic Hyperplasia
Interventions: ProTouch Laser Enucleation of Prostate (LEP), Transurethral Resection of Prostate (TURP); Procedure
Lead sponsor: Boston University; Other
Eligibility: 50 Years and older · Male only
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Benign Prostatic Hyperplasia (BPH)
Interventions: AQUABEAM System, Transurethral Resection of the Prostate (TURP); Device · Procedure
Lead sponsor: PROCEPT BioRobotics; Industry
Eligibility: 45 Years to 80 Years · Male only
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 12
States / cities: Birmingham, Alabama • La Mesa, California • Los Angeles, California + 9 more

Conditions: Prostate Cancer
Interventions: Prostate Ablation; Procedure
Lead sponsor: University of Chicago; Other
Eligibility: 22 Years and older · Male only
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Hyde Park, Illinois • Cincinnati, Ohio

Conditions: Malignant Digestive System Neoplasm, Metastatic Head and Neck Carcinoma, Metastatic Kidney Carcinoma, Metastatic Malignant Neoplasm in the Spine, Metastatic Malignant Neoplasm of Unknown Primary, Metastatic Melanoma, Prostate Carcinoma Metastatic in the Bone, Sarcoma, Solid Neoplasm, Spinal Cord Compression, Stage IV Breast Cancer AJCC v6 and v7, Stage IV Lung Non-Small Cell Cancer AJCC v7, Thyroid Gland Carcinoma
Interventions: Computed Tomography, Quality-of-Life Assessment, Questionnaire Administration, Stereotactic Radiosurgery, Thermal Ablation Therapy; Procedure · Other · Radiation
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Liver Neoplasms, Hepatic Cancer, Liver Cancer
Interventions: Thermal Ablation, Standard External Beam Radiation Therapy; Procedure
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Prostate Cancer, Benign Prostatic Hypertrophy, Bladder Stones, Kidney Stones
Interventions: NV-VPAC1 PCa Urine Diagnostic Test; Diagnostic Test
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years to 80 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Benign Prostatic Hyperplasia
Interventions: Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA) Therapy, Finasteride and Alfuzosin; Device · Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 50 Years and older · Male only
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 7
States / cities: Denver, Colorado • Chicago, Illinois • Rochester, Minnesota + 4 more

Search by objective public record fields.

A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence

Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate

Intradetrusor Botox at the Time of Transurethral Resection of the Prostate for Mixed Lower Urinary Tract Symptoms

A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization

Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia

Optimizing Pain Control in Transurethral Resection of the Prostate

Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterjet Ablation of the Prostate for Mixed Lower Urinary Tract Symptoms

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II

Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP)

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)

Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms

Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.

Minimally Invasive Surgical Therapy for BPH